<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>14</o:Revision>
  <o:TotalTime>248</o:TotalTime>
  <o:Created>2006-01-10T10:42:00Z</o:Created>
  <o:LastSaved>2006-01-12T12:48:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>758</o:Words>
  <o:Characters>4324</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>36</o:Lines>
  <o:Paragraphs>8</o:Paragraphs>
  <o:CharactersWithSpaces>5310</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:navy;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='mso-field-code:"HYPERLINK \0022http\:\/\/www\.ebi\.ac\.uk\/interpro\/index\.html\0022 \\o \0022To the InterPro database\0022"'><span
style='text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1027" type="#_x0000_t75" style='width:139.5pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=186 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1027"><![endif]></span></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>DNA Topoisomerase<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Functions of DNA Topoisomerases<o:p></o:p></span></h2>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText style='text-indent:36.0pt'>There are a number of different
types of topoisomerases, each specialising in a different aspect of DNA
manipulation.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Accessing DNA</h3>

<p class=MsoBodyText style='text-indent:36.0pt'>During transcription and DNA
replication, the DNA needs to be unwound in order for the
transcription/replication machinery to gain access to the DNA so it can be
copied or replicate, respectively.<span style="mso-spacerun: yes"> 
</span>Topoisomerase I can make single-stranded breaks to allow these processes
to proceed.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Removing DNA Supercoils</h3>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>During
transcription and DNA replication, the DNA helix can become either over-wound
or under-wound.<span style="mso-spacerun: yes">  </span>For instance, during
DNA replication, the progress of the replication fork generates positive
supercoils ahead of the replication machinery and negative supercoils behind
it.<span style="mso-spacerun: yes">  </span>Such tensional problems also exist
when transcribing DNA to make an RNA copy for protein synthesis.<span
style="mso-spacerun: yes">  </span>During these processes, the DNA can be
supercoiled to such an extent that if left unchecked it could impede the
progress of the protein machinery involved.<span style="mso-spacerun: yes"> 
</span>This is prevented by topoisomerase I, which makes single-stranded nicks
to relax the helix.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Strand Breakage during Recombination</h3>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Before
the chromosomes separate from one another during cell division, they are able
to exchange genetic information through a process known as recombination, where
physical pieces of DNA on one chromosome can be swapped for DNA on the matching
sister chromosome in order to shuffle the genetic information.<span
style="mso-spacerun: yes">  </span>Topoisomerase III can introduce
single-strand breaks that are required for DNA to be exchanged by adjacent
chromosomes.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Chromosome Condensation </h3>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>During
the cell cycle, chromosomes must be alternatively condensed and decondensed at
specific stages.<span style="mso-spacerun: yes">  </span>Topoisomerase II
(gyrase) acts as a molecular motor, using the energy gained from ATP hydrolysis
to introduce tight supercoils into the DNA helix in order to condense the
chromosome.<span style="mso-spacerun: yes">  </span>Because this process must
be highly regulated, topoisomerase II can form molecular complexes with
important cell cycle regulators (such as p53, TopBP1, 14-3-3 epsilon, and Cdc2)
to ensure that chromosome condensation occurs at the correct time in the cell
cycle.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Disentangling Intertwined DNA</h3>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>During
cell division, once the chromosomes have been replicated, they must separate
and travel to opposite ends of the cell to become part of two separate daughter
cells.<span style="mso-spacerun: yes">  </span>Topoisomerases IV acts to
disentangle the replicated daughter strands by making double-strand breaks that
allow one duplex to pass through the other.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Topoisomerases as Drug Targets<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Topoisomerases
have been the focus for the treatment of certain diseases.<span
style="mso-spacerun: yes">  </span>Bacterial gyrase (topoisomerase II) and
topoisomerase IV are the targets of two classes of antibiotic drugs: quinolones
and coumarins.<span style="mso-spacerun: yes">  </span>These antibiotics are
used to treat an assortment of different diseases, such as pneumonia,
tuberculosis and malaria, by inhibiting DNA replication in the bacteria
responsible.</p>

<p class=MsoBodyText style='text-indent:36.0pt'>Eukaryotic topoisomerases I and
II are the targets of an increasing number of anti-cancer drugs that act to
inhibit these enzymes by blocking the reaction that reseals the breaks in the
DNA.<span style="mso-spacerun: yes">  </span>Often the binding of the drug is
reversible, but if a replication fork runs into the blocked topoisomerase, then
a piece of the gapped DNA strand not bound by the topoisomerase could be
released, creating a permanent breakage in the DNA that leads to cell death.<span
style="mso-spacerun: yes">  </span>Most of these inhibitors are selective
against either topoisomerase I or II, but some can target both enzymes.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText style='text-indent:36.0pt'>Topoisomerase I inhibitors
induce single-strand breaks into DNA, and can work by a variety of
mechanisms.<span style="mso-spacerun: yes">  </span>Some drugs, such as
camptothecins, inhibit the dissociation of topoisomerase and DNA, leading to
replication-mediated DNA damage, which can be repaired more efficiently in
normal cells than in cancer cells (deficient for DNA repair).<span
style="mso-spacerun: yes">  </span>Topoisomerase I inhibitors can also cause
gene inactivation through chromatid aberrations.</p>

<p class=MsoBodyText style='text-indent:36.0pt'>Topoisomerase II inhibitors,
such as anthracyclines, are amongst the most widely used anti-cancer
agents.<span style="mso-spacerun: yes">  </span>These drugs are potent inducers
of double strand breaks in DNA, and can cause arrest in the cell cycle at the
G2 stage, the latter occurring by disrupting the interaction between
topoisomerase II and regulators of the cell cycle, such as Cdc2.<span
style="mso-spacerun: yes">  </span>Topoisomerase II inhibitors can cause a wide
range of chromosomal aberrations, and can act by either stabilising topoisomerase
II-DNA complexes that are easily cleaved, or by interfering with the catalytic
activity of the enzyme, both resulting in double-strand breaks in the DNA.</p>

<p class=MsoBodyText style='text-indent:36.0pt'>There are also dual inhibitors
that target both topoisomerase I and II, which increases the potency of the
anti-cancer effect.<span style="mso-spacerun: yes">  </span>These drugs work by
a variety of means: by recognising structural motifs present on both enzymes,
by linking separate topoisomerase inhibitors together into a hybrid drug, or by
using inhibitors that bind to and intercalate DNA.<span style="mso-spacerun:
yes">  </span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page3.htm">What InterPro Tells Us</a><o:p></o:p></span></h2>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm">DNA Topoisomerases,
Unravelling DNA Strands</a><o:p></o:p></span></h2>

</div>

</body>

</html>
